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THE distribution of radioactive phosphorus can be investigated in vivo using
a thin-walled G.M. counter tube. The maximum range for beta paitioles of
P32 in soft tissue is 8 mm., but the half-value thickness is only of the order of
0-6 to 0-8 mm. Consequently, measurements on the skin can only indicate the
amount of phosphorus in the superficial layers of the body (effectively some
3 mm. deep). However, under favourable conditions, such measurements can
be used to demonstrate the increased phosphorus up-take by malignant tumours.
Low-Beer, Glenn-Bell, McCorkle and Stone (1946) have used this method with
some success, as a diagnostic procedure, but its value is reduced by the low
penetration of the beta rays and by the increased up-take also found in inflam-
matory conditions. The present series of experiments (started in November,
1948) was undertaken to investigate possible changes in the phosphorus content
of malignant tumours during and after a course of X-ray treatment, and to
attempt to correlate such changes with the reaction of the tumour to the
irradiation.
MATERIAL AND METHOD.
Only cases of mammary carcinoma with the tumour attached to the 'skin
were selected; the patients were in good general health.
On each occasion a tracer dose ofabout 150 1AC- P.2 was given by intravenous
injection in 5 c.c. phosphate buffer at pH 7-35. It has been found advisable to
check, by counter measurements, that the radioactive material has actuaRy left
the site of injection, as, even after taking more than ordinary care, some
unsatisfactory injections have been detected. This is particularly important, of course, when giving the isotope therapeutically, as dose calculations assume
that the whole of the material enters the blood stream. No side effects of the
injection were observed. Assuming uniform distribution, a body weight of
60 kg. and a biological half life of 8 days, the dose dehvered was about 0-I r
in the first day and about I
-I r over a period of some 4 weeks. The tumour
may have received 4 to 8 times the dose calculated above, a total which is in
excess of the generally agreed
" tolerance
" level. This was, however, of no
consequence as the site was tore'ceive an X-ray dose of 3000 to 4000 r.
A number of sites over the tumour, on the diseased breast, and at corres-
ponding points on the normal breast, were marked with gentian violet, and
measurements of the activities were made with a counter tube applied directly46 F. ELLIS, CORNELIA HOCH-LIGETI AND R. aLIVER
to the skin. A GM4 counter (General Electric Co., Ltd., England) was used,
with conventional quenching and scaling circuits, the 0-001 inch thick dura-lumin
window being covered with a sheet of cellophane to give some protection, and
to avoid possible contamination ofthe window by the skin.
Some difficulty was experienced because of the rise of temperature of the
counter in contact with the skin; this led to a slight fall in count rate due to a
.9bift of the counter voltage characteristic. In order to ensure that theoperating
point did not leave the plateau of the characteristic curve, the initial setting
was some 150 volts above the critical voltage. The' counter was checked against
a standard beta ray source (uranium oxide with filter to remove alpha rays)
before, and at intervals during the skin measurements, and the operating voltage
adjusted slightly to maintain the same count rate. The background rate was
checked before and after the series. In each case the complete set of measure-
ments wasrepeated and a mean value for each site was used. It was not feasible
to prolong the counting time at any site ab'ove about 3 minutes. As the count
rates with this tracer dose were rather low, the measurements were usually
limited to 1000 counts (3 per cent standard deviation) or, after several days
and over normal tissue, to only 100 counts (10 per cent standard deviation).
Consequently, the ratios of count rates over tumour and normal skin were not
obtained very accurately, but the results sufficed to demonstrate large changes.
Series of measurements were made before, during, and 4 to 6 weeks after the
treatment, at which time the X-ray erythema had subsided but the skin of the
irradiated breast remained highly pigmented. Observations were made on
altemate days during 2 to 3 weeks.
After intravenous injection, the radioactive phosphorus could be demon-
strated immediately (5 to 8 seconds) in the tissues of the breast, but the con-
centrations continued to increase in both healthy and dis6ased breasts for 10 to
15 minutes. Considerably lower count rates were observed when the next series
of measurements were made after an interval of 2 days, a change probably due
to the excretion of P32' Thereafter the fall was found to follow a roughly
exponential form, corresponding to a
" biological half-hfe
" of between 7 and 9
days. Typical cases are ifustrated in Fig. 1. The excretion of P.2 was not
followed up with patients, but in prehn-iinary experiments with rats it was found
that, after intra-cardiae injection, a large percentageofP32was excreted in the
urine in the first 48 hours. After that time, noP32 could be demonstrated in the
urine, but a smaH quantity continued to be found in the faeces over a period of
at least 30 days.
The X-ray treatment was the same in Cases I to 4. Tumour dose of 3400 r
(200 Kv., 1-0 mm., Cu. H.V.L.) was given (fractioned as .260 r on alternatedays)
using a glancing field technique. With Case 5 the whole chest wall received
low voltage irradiation (140 Kv., 0-25 mm., Cu. H.V.L.) to a total of 2500 r in
5 weeks.
Ca8e record8.
(1) Mr8. L. C-, aged 57. Tumour in the left breast; histologicaRy sofid
trabecular, polygonal-celled carcinoma. The tumour was at least 15-0 cm. in
diameter, hardest in the upper and outer quadrant. The skin was extensively
involved. The mass was attached to muscle but not to the chest wall.47 RADIOACTIVE PHOSPHORUS IN BREAST TUMOURS
Days
FiG. l.-Fall of count rate over tumours in two typical cases as compared with physical
decay.
(a) Physical decay.
(b) and (c) Count rates in two patients when not receiving X-ray treatment.
The actual count rates before and during the X-ray treatment are given in
Table I. Apart from the breast measurements, readings taken over the forehead
TABLE I.-Average CountsIMinute Above Background.
Before and during X-ray treatment.
Site.
Date 18.ii. 21.ii. 23.ii. 25.ii. 28.ii. 2.iii. 4.iii. 7. i.
Tumour 801 260 240 197 118 86 61 42
Tumour edge 563 124 108 94 66 50 45 36
Diseased breast 635 117 89 66 53 51 41
Normal breast 359 87 63 77 63 41 41 28
Normal breast 171 87 65 50 43 41 48 42 33
Axilla, tumour side 500 122 149 102 64 74 47 32
Axilla, normal side 430 159 149 98 80 76 36
Forehead 444 324 275 200 162 147 118 109
and over both axillae are also included. It is ofinterest to note that thereadings
,over the forehead (indicating thep.,2 content of the frontal bone) increased to
the level found over the tumour and then decreased more slowly than the latter.
Values ofthe ratio ofcount rates overthe diseased breast to those overthehealthy
breast are presented in Fig. 2a and 2b. Before treatment the ratio of the count
rates remained constant, but a break in the curves was observed 3 days after the
irradiations started. The measurements in Fig. 2b were made 6 weeks after the
end of the X-ray treatment, when the whole surface of the irradiated breast
had a higherp.2 content than the healthy breast, the ratio between the two
being similar to that before treatment.
The patient's condition deteriorated, and 7 months a'fter treatment she died
with extensive ulcerative carcinoma.48 F. ELLIS. CORNELIA HOCH-LIGETI AND R. OLIVER
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FIG. 2.' Ratio of count rate over diseased to that over normal breast.
Mr8. L. C-
X X x Ratios over tumour.
9 o o Ratios over tumour periphery.
+ + + Ratios over apparently norrnal tissue on diseased breast.
(a) Before and during X-ray treatment. Arrow marks first treatment.
(b) Six weeks after X-ray treatment.
The curve is shown dotted between the first two measurements after the injection of P.32,
during which time the ratios were not steady.
(2) Mrs. A. W-, aged- 60. Polygonal-ceRed carcinoma in the right breast.
The tumour measured II X 9 X 6 cm. No palpable axifarv alands.
In this, our firstexploratory case, X-ray treatment started on the day follow-
ing the injection of a tracer dose Of P32. The results are given in Fig. 3a. A
sudden drop in the ratio occurred after the third irradiation. Four weeks after
the end ofthe treatment a second tracer dose wasgiven, and the results obtained
are shown in Fig. 3b. For the first three readings the skin was still very red.
By the time the erythema had subsided the count rates were ratherlow, butthey
appeared to behigher than normal over the whole ofthe diseased breast, without
any locahzed. area ofhigh activity.
Two months after the irradiation total mastectomy was carried out. The
patient is in good general condition with no evidence of recurrence 2i years
after the treatment.
(3) -Mrs. F. N-, aged 65. Patient had a large hard right breast, with
peau d'orange, containing a tumour, with ulceration and infiltration of the skin.
There was pleural effusion on the left side.49 RADIOACTIVE PHOSPHORUS IN BREAST TUMOURS
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FIG. 3.-Ratio of count rate over diseased to that over normal breast.
Mm A. W- :
x x x Ratios over tumour.
Ratios over tumour periphery.
+ + + Ratios over apparently normal tissue on diseased breast.
(a) During X-ray treatment. Arrow marks first treatment.
(b) Four weeks after X-ray treatment. Erythema still present.
The curve is shown dotted between the first two measurements after the injection Of P32,
during which time the ratios were not steady.
The measurements with this patient are ofparticular interest as she received
a course of stilboestrol before starting X-ray treatment. As shown in Fig. 4a
the ratio of count rates over the two breasts remained constant (or even tended
to rise) during the stilboestrol treatment, which produced little chnical improve-
ment. Five weeks after the stilboestrol treatment was finished, X-ray treatment
started. After two X-ray doses a sudden fall in the ratio was again observ-ed
(Fig. 4b), but a third series ofmeasurements, 4 weeks after the completion ofthe
X-rav treatment, indicated ratios as high as those obtained before treatment
(Fig. 4c).
The patient did not improve considerably. One year after treatment she
developed neurological symptoms and died.
(4) Mr8. H-, aged 72. Advanced carcinoma of the right breast, a diffuse
thickening occupying most ofthe breast.
Fig. 5 shows the measurements over the diseased breast relative to those over
the normal breast. The ratios, fairly constant before treatment, dropped
suddenlv afterthesecondirradiation and continued to falltowardsunity. Because
of the age of this patient the injection OfP32 was not repeated after treatment.
(5) Miss E. R-, aged 61. Stage III tumour of left breast.
Although in this case the whole chest wall was irradiated, the ratio of count
rates over the diseased and normal breasts showed a sudden drop after the
second irradiation (Fig. 6), indicating a diminution OfP.2 uptake in the affected
as compared with the normal breast. Measurements were also made over an
isolated skin nodule separated from the primary growth by 6 cm. ofapparently
normal skin. The initial count rate over this nodule was onlyslightly lower than
that over the primary growth, and the exactlv similar changes were observed
for these two sites.
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FIG. 4.-Ratio of count rate over disea-sed to that over normal breast.
Mrs. F. N- :
x x x Ratios over tumour.
0 0 0 Ratios over tumour periphery.
+ + + Ratios over appa-rently normal tissue on diseased breast.
(a) During stilboestrol treatment.
(b) Before and during X-ray treatment. Arrow marks first X-ray treatment.
(e) Four weeks after X-ray treatment.
The curve is shown dotted 'between the first two measurements after the injection Of P.121
during which time the ratios were not steady.RADIOACTIVE PHOSPHORUS IN BREAST TUMOURS 51
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FIG. 5.-Ratio of count rate over diseased to that over normal breast.
Mr8. H-:
x x x Ratios over tumour.
9 * 4D Ratios over tumour periphery.
+ + + Ratios over apparently normal tissue on diseased breast.
Before and during X-ray treatment. Arrow marks first treatment.
The curve is shown dotted between the first two measurements after the injection Of P32,
during which time the ratios were not steady.
DISCUSSION.
Although the number of cases is very small, the results appear to be of
sufficient interest to justify publication, particularly as the present series of
experiments has had to be discontinued because the team has dispersed. At a
later date the authors hope to continue the investigation, although working at
different institutions.
The countrate due to P..2 was fodnd to be very muchhigher (between 3 and 8
times) over malignant mammary tumours attached to the skin, than over the
correspondingparts ofthehealthy breast. Ahigher count rate was also recorded52 F. ELLIS. CORNELIA HOCH-LIGETI AND R. OLIVER
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FiG. 6.-Ratio of count rate over diseased to that over normal breast.
Miss E. R-:
x x x Ratios over tumour.
0 0 0 Ratios over tumour periphery.
+ + + Ratios over apparently normal tissue on diseased breast.
Ratios over isolated skin nodule.
Before and during X-ray treatment. Arrow marks first treatment.
over parts of the diseased breast remote from the palpable tumour, but it is
not possible to decide whether this is due to a greater tissue vascularity or to
some microscopic or sub-microscopic spread of the tumour.
The exponential rate ofdisappearance OfP..2 was found to be approximately
the same for diseased and normal breasts, but in all cases receiving X-ray treat-
ment, a sudden fall in count rate over the tumour and over that breast was
observed after-the second or third irradiation.
it appeared that this sudden fall occurred first over the peripheral parts of
the tumour, a drop over the central part following after one or two further
irradiations.
In experiments with rats, X-radiation produced a marked inhibition Of P32
uptake in thethyomonucleic acid fraction in tumours and other tissues withhigh
mitotic activity (Hevesy, 1945 ; Hohnes, 1947). Although a different technique
was used, these findings may account for the results reported above. It is not
possible to decide, from the present experiments, whether the changes observed
during the course ofX-ray treatment ofpatients are due to change in metabolism
ofthe tumour cells or to vasculardamage. However, it may bepossible to decide
this by suitably controlled experiments.
Count rates, much higher than normal, were observed over areas of X-ray
erythe'ma, and it is therefore important to postpone measurements after treat-
ment until this reaction completely clears. 'The ratios of count rates over the
two breasts were then found to be similar to those obtaining before X-ray treat-
ment, but, as the primary growths were still present in aH these cases, it is notRADIOACTIVE PHOSPHORUS IN BREAST TUMOURS 53
possible to say what the ratio would be after a treatment when the primary
tumour has disappeared.
SUMMARY.
Tracer doses of about 1501'C' P32 were given intravenously to five patients
with malignant breast tumours attached to the skin, and measurements made
with a beta counter applied directly to the skin. Series of measurements were
made before'during, and after X-ray treatment, and, in one case, during a
course of stilboestrol treatment. The count rate recorded was much higher
over the tum'our, and to a lesser extent over the whole of that breast, than over
corresponding sites on the normal breast. The exponential rate ofdisappearance
'of P32 was found to be approximately the same for both breasts, but after the
second or third X-rkv treatment a sudden fall was obseirved in the count rate
over the tumour and over that breast relati've to that over the normal breast.
This result was obtained in all,cases, including one in which both breasts received
the same low voltage (140 Kv.) irradiation. No such,change occurred during
stilboestrol treatment in a case which did notrespond clinically. Aftererythema
had subsided the ratios of measurements over the two breasts were found to be
similar to those before treatment- but the primary growth was still present in
all these cases.
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